We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Intravenous Sodium Fluorescein Versus Oral Phenazopyridine for Ureteral Patency

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02757417
Recruitment Status : Withdrawn (Study never started)
First Posted : May 2, 2016
Last Update Posted : May 6, 2022
Megan Billow
Graham Chapman
Sangeeta Mahajan
Alex Soriano
Sherif El-Nashar
Information provided by (Responsible Party):
University Hospitals Cleveland Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : January 2018
Estimated Study Completion Date : December 2019